Explore 3 Stock Ideas & Industry Insights Download Free Report

Earnings

Trimble (NASDAQ:TRMB) Q3 Revenue Rises 7% to USD 966.8M as ARR Hits Record USD 2.56B

Annualized recurring revenue reached USD 2.56 billion. Subscription and services revenue rose to USD 642.5 million from USD 598.7 million, and product revenue rose to USD 324.3 million from USD 302.5 million. Chief executive Rob Painter said results came in ahead of plan on …

Nitish Kishor | 04 November 2026

Townsquare Media (NYSE:TSQ) Q3 Earnings: Revenue Beats, Dividend Suspended

Digital advertising was the main growth driver, with revenue of USD 45.3 million compared with USD 40.2 million, a 12.7% increase. Segment profit in digital advertising was USD 8.5 million, little changed from USD 8.6 million, as direct operating expenses rose to USD 36.9 …

Nitish Kishor | 04 November 2026

Twin Disc (NASDAQ:TWIN) Q1 EPS of USD 0.24 Tops Estimate as Sales Rise 10.9%

The increase of USD 8.7 million was led by the Veth propulsion line in the Netherlands, where sales grew 17.5%, and by the Katsa operation in Finland, up 31.9% on stronger European military demand. Marine and propulsion products improved 14.4%, and industrial products rose …

Nitish Kishor | 04 November 2026

Uber (NYSE:UBER) Q3 Gross Bookings Climb 20% to USD 59.8B as Non-GAAP EPS Reaches USD 0.88

Trips grew 16% to 4.1 billion, driven by a 14% rise in monthly active platform consumers to 215 million and a 2% rise in monthly trips per consumer. Chief executive Dara Khosrowshahi noted a fifth consecutive quarter of gross bookings growth above 20%.

Nitish Kishor | 04 November 2026

UroGen Pharma (NASDAQ:URGN) Q3 Revenue Jumps to USD 89.0M, Swings to Operating Profit

The USD 61.5 million revenue increase came mainly from Zusduri, the bladder cancer therapy launched late in the second quarter of 2025. Zusduri sales reached USD 68.0 million, compared with USD 1.8 million in the prior year quarter, while Jelmyto sales slipped to USD …

Nitish Kishor | 04 November 2026

United Therapeutics (NASDAQ:UTHR) Q3 Revenue Rises 4% to USD 832.5M as EPS Misses at USD 5.71

Total Tyvaso net product sales rose 5% to USD 503.8 million, but the two formulations moved in opposite directions. Tyvaso DPI sales increased 13% to USD 378.5 million, helped by USD 43.9 million of higherVolumeand a price increase, partly offset by larger gross-to-net deductions. …

Nitish Kishor | 04 November 2026

Marriott Vacations (NYSE:VAC) Q3 Contract Sales Surge 29% to USD 565 Million

Vacation Ownership contract sales rose 29% to USD 565 million, and volume per guest increased 30% to USD 4,822, even though tours declined 2% to 107,687. Management credited owner engagement initiatives, including enhanced owner benefit levels and the Inner Circle platform, and said developmentMarginbenefited …

Nitish Kishor | 04 November 2026

Versigent (NYSE:VGNT) Q3 Revenue Beats at USD 2.45 Billion as Asia Pacific Sales Jump 18%

Commodity pass-through accounted for USD 112 million of the USD 164 million gain, as customers reimbursed higherCommoditycosts. Net pricing added USD 21 million, currency added USD 20 million, mostly from the Chinese renminbi, andVolumeadded only USD 11 million.

Nitish Kishor | 04 November 2026

Vishay Precision (NYSE:VPG) Q3 Revenue Rises 6.7% to USD 85.1M as Backlog Hits USD 151M

Growth was concentrated in Sensors, where revenue climbed to USD 38.4 million from USD 31.6 million. Measurement Systems rose 7.6% to USD 22.1 million, while Weighing Solutions slipped 10.7% to USD 24.6 million. Measurement Systems posted the highest grossMarginof the three at 56.5%, up …

Nitish Kishor | 04 November 2026

Viridian Therapeutics (NASDAQ:VRDN) Q3 Revenue Beats at USD 25.8M on Veligrotug Launch

Net product revenue was USD 24.7 million, or about 96% of the total, against none a year ago. License revenue fell to USD 0.1 million from USD 70.0 million, and collaboration revenue rose to USD 1.0 million from USD 0.6 million. Total revenue therefore …

Nitish Kishor | 04 November 2026
Support

Hi! How can we help you today?

Loading…